Journal Mobile Options
Table of Contents
Vol. 13, No. 2, 2002
Issue release date: February 2002

Corticobasal Degeneration and Frontotemporal Dementia Presentations in a Kindred with Nonspecific Histopathology

Boeve B.F. · Maraganore D.M. · Parisi J.E. · Ivnik R.J. · Westmoreland B.F. · Dickson D.W. · Hutton M. · Hardy J. · Caselli R.J. · Petersen R.C.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


We report the clinical, neuropsychological, electroencephalographic and radiologic findings in a kindred with varying clinical presentations of a neurodegenerative disorder. Postmortem examination of one member with clinically suspected corticobasal degeneration (CBD) revealed nonspecific histopathology maximally involving the frontoparietal cortex with negligible degenerative changes in the basal ganglia and substantia nigra. The findings in this and other kindreds demonstrate that (1) similar findings on ancillary testing can occur in relatives presumably suffering from the same pathophysiologic process despite dissimilar clinical presentations, (2) the ‘CBD syndrome’ is not specific for CBD, (3) extrapyramidal dysfunction can exist in the absence of appreciable basal ganglia and nigral degeneration, (4) nonspecific histopathology can underlie familial focal/asymmetric cortical degeneration syndromes and (5) many of the findings in CBD are comparable to those reported in frontotemporal dementia.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Brun A, Englund B, Gustafson L, Passant U, Mann DMA, Neary D, Snowden JS: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416–418.
  2. Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546–1554.
  3. Boeve B, Maraganore D, Parisi J, Ahlskog J: A case presenting clinically as cortical-basal ganglionic degeneration without neuronal achromasia (abstract). Mov Disord 1996;11:356–357.
  4. Brown J, Lantos P, Rossor M: Familial dementia lacking specific pathological features presenting with clinical features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998;65:600–603.
  5. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Heutink P: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702–705.
  6. Kokmen E, Smith G, Petersen R, Tangalos E, Ivnik R: The short test of mental status: Correlations with standardized psychometric testing. Arch Neurol 1991;48:725–728.
  7. Mattis S: Dementia Rating Scale: Professional Manual. Odessa, Psychological Assessment Resources, 1988.
  8. Smith G, Ivnik R, Malec J, Petersen R, Kokmen E, Tangalos E: The Mayo Cognitive Factor Scores (MCFS): Derivation of a short battery and norms for factor scores. Neuropsychology 1994;8:194–202.

    External Resources

  9. Wechsler D: Wechsler Adult Intelligence Scale-Revised (Manual). San Antonio, The Psychological Corporation, 1981.
  10. Reitan R: Validity of the Trail-Making Test as an indication of organic brain damage. Percept Mot Skills 1958;8:271–276.
  11. Stroop J: Studies of interference in serial verbal reaction. J Exp Psychol 1935;18:643–662.
  12. Trenerry M, Crosson B, DeBoe J, Leber W: Stroop Neurological Screening Test (Manual). Odessa, Psychological Assessment Resources, 1989.
  13. Kaplan E, Goodglass H, Weintraub S: The Boston Naming Test. Boston, Kaplan & Goodglass, 1978.
  14. Benton A, Hamsher K: Multilingual Aphasia Examination (Manual). Iowa City, University of Iowa, 1978.
  15. Heaton R: Wisconsin Card Sorting Test Manual. Odessa, Psychological Assessment Resources, 1981.
  16. Wechsler D: Wechsler Memory Scale-Revised (Manual). New York, Psychological Corporation, 1987.
  17. Rey A: L’Examen Clinique en Psychologie. Paris, Presses Universitaires de France, 1964.
  18. Rey A: L’examen psychologique dan les cas d’encéphalopathie traumatique. Arch Psychol 1941;28:286–340.
  19. Osterrieth P: Le test de copie d’une figure complexe. Arch Psychol 1944;30:206–356.
  20. Benton A, Hamsher K, Varney N, Spreen O: Contributions to Neuropsychological Assessment. New York, Oxford University Press, 1983.
  21. Hooper: The Hooper Visual Organization Test (Manual). Beverly Hills, Western Psychological Services, 1958.
  22. Ivnik R, Malec J, Smith G, Tangalos EG, Petersen RC, Kokmen E, Kurland LT: Mayo’s Older American Normative Studies: WAIS-R, WMS-R, and AVLT norms for ages 56–97. Clin Neuropsychol 1992;6(suppl):1–104.
  23. Ivnik R, Malec J, Smith G, Tangalos E, Petersen R: Neuropsychological tests’ norms above age 55: COWAT, BNT, MAE Token, WRAT-R reading, AMNART, STROOP, TMT and JLO. Clin Neuropsychol 1996;10:262–278.
  24. Lucas J, Ivnik R, Smith G, Bohac D: Normative data for the Mattis Dementia Rating Scale. Arch Clin Neuropsychol 1998;13:41.
  25. Caselli R: Focal and asymmetric cortical degeneration syndromes. Neurologist 1995;1:1–19.
  26. Lang A, Riley D, Bergeron C: Cortical-basal ganglionic degeneration; in Calne D (ed): Neurodegenerative Diseases. Philadelphia, Saunders, 1994, pp 877–894.
  27. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, Poewe W, Jellinger K, Chaudhuri KR, D’Olhaberriague L, Pearce RKB: Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64:184–189.
  28. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, Dickson DW, Kokmen E, Petersen RC: Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795–800.
  29. Neary D, Snowden J, Mann D: Familial progressive aphasia: Its relationship to other forms of lobar atrophy. J Neurol Neurosurg Psychiatry 1993;56:1122–1125.
  30. Neary D, Snowden J, Mann D: The clinical pathological correlates of lobar atrophy. Dementia 1993;4:154–159.
  31. Rebeiz J, Kolodny E, Richardson E: Corticodentatonigral degeneration with neuronal achromasia: A progressive disorder of late adult life. Trans Am Neurol Assoc 1967;92:23–26.

    External Resources

  32. Rebeiz J, Kolodny E, Richardson E: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20–33.
  33. Pogacar S, Williams R: Alzheimer’s disease presenting as slowly progressive aphasia. RI Med J 1984;67:181–185.
  34. Jagust W, Davies P, Tiller-Borcich J, Reed B: Focal Alzheimer’s disease. Neurology 1990;40:14–19.
  35. Ball J, Lantos P, Jackson M, Marsden C, Scadding J, Rossor M: Alien hand sign in association with Alzheimer’s histopathology. J Neurol Neurosurg Psychiatry 1993;56:1020–1023.
  36. Lang A, Bergeron C, Pollanen M, Ashby P: Parietal Pick’s disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436–1440.
  37. Cambier J, Masson M, Dairou R, Henin D: Etude anatomo-clinique d’une forme pariétale de maladie de Pick. Rev Neurol (Paris) 1981;137:33–38.

    External Resources

  38. Knopman D, Mastri A, Frey W, Sung J, Rustan T: Dementia lacking distinctive histologic features. Neurology 1990;40:251–256.
  39. Knopman DS: Overview of dementia lacking distinctive histology: Pathological designation of a progressive dementia. Dementia 1993;4:132–136.

    External Resources

  40. Brown J, Ashworth A, Gydesen S, Sorenson A, Rosser M, Hardy J, Collinge J: Familial non-specific dementia maps to chromosome 3. Hum Mol Genet 1995;4:1625–1628.
  41. Neary D, Snowden J, Mann D, Northen D, Goulding P, Macdermott N: Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 1990;53:23–32.
  42. Brun A: Frontal lobe degeneration of non-Alzheimer type revisited. Dementia 1993;4:126–131.
  43. Goldfarb L, Petersen R, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, et al: Fatal familial insomnia and familial Creutzfeldt-Jakob disease: Disease phenotype determined by a DNA polymorphism. Science 1992;258:806–808.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50